Ayrton Drugs Manufacturing Limited reported unaudited earnings results for the half year ended December 31, 2016. For the period, the company reported revenue of GHC 17,948,340 against GHC 21,325,226 a year ago. Operating profit was GHC 3,014,139 against GHC 3,347,035 a year ago. Profit before taxation was GHC 2,362,410 against GHC 2,073,947 a year ago. Profit for the period was GHC 2,117,192 against GHC 1,940,045 a year ago. Earnings per share were GHC 0.0098 against GHC 0.0090 a year ago. Net cash flows from operating activities were GHC 1,285,087 against GHC 933,374 a year ago. Purchase of property, plant and equipment was GHC 687,160 against GHC 393,304 a year ago.